Comparison of the Effectiveness and Safety of Vildagliptin Add-On to Metformin Versus Other Oral Dual Antidiabetes Agents in Patients with Type 2 Diabetes: The China Prospective Diabetes Study-Reference-Cited by-同舟云学术

Comparison of the Effectiveness and Safety of Vildagliptin Add-On to Metformin Versus Other Oral Dual Antidiabetes Agents in Patients with Type 2 Diabetes: The China Prospective Diabetes Study

Published:2019-06-20 Issue:4 Volume:10 Page:1391-1405
ISSN:1869-6953
Container-title:Diabetes Therapy
language:en
Short-container-title:Diabetes Ther

Author:

Zang Li,Han Yin,Chen Lixian,Hu Daqing,Jin Hui,Yang Nailong,Shi Xiaoyun,Liang Linlang,Liu Mingming,Fan Hong,Li Quanmin,Mu Yiming

Funder

Novartis

Publisher

Springer Science and Business Media LLC

Subject

Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

http://link.springer.com/content/pdf/10.1007/s13300-019-0645-z.pdf

Reference45 articles.

1. Wang L, Gao P, Zhang M, et al. Prevalence and ethnic pattern of diabetes and prediabetes in China in 2013. JAMA. 2017;317(24):2515–23. https://doi.org/10.1001/jama.2017.7596 .

2. Ji L, Hu D, Pan C, et al. Primacy of the 3B approach to control risk factors for cardiovascular disease in type 2 diabetes patients. Am J Med. 2013;126(10):925 e911–22. https://doi.org/10.1016/j.amjmed.2013.02.035 .

3. Zhang L, Ji L, Guo L, et al. Treatment patterns and glycemic control in older adults with type 2 diabetes mellitus receiving only oral antidiabetes drugs in China. Diabetes Technol Ther. 2015;17(11):816–24. https://doi.org/10.1089/dia.2015.0094 .

4. American Diabetes Association. Standards of medical care in diabetes—2014. Diabetes Care. 2014;37(Supplement 1):S14–80.

5. Turner RC, Cull CA, Frighi V, Holman RR. Glycemic control with diet, sulfonylurea, metformin, or insulin in patients with type 2 diabetes mellitus: progressive requirement for multiple therapies (UKPDS 49). UK Prospective Diabetes Study (UKPDS) Group. JAMA. 1999;281(21):2005–12.

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Vildagliptin Versus α-Glucosidase Inhibitor as Add-On to Metformin for Type 2 Diabetes: Subgroup Analysis of the China Prospective Diabetes Study;Diabetes Therapy;2019-12-10